JAMP FINGOLIMOD
Identification of Jamp Fingolimod
| No description |
Google image searchProduct monograph
Active ingredient
fingolimod (fingolimod hydrochloride), 0.5 MG
DIN: 02487772
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 31-OCT-2019
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AE — Sphingosine-1-phosphate (S1P) receptor modulators (ATC, ATC/DDD)
- L04AE01 — FINGOLIMOD (ATC/DDD)
Reference brand drug: Gilenya
